comparemela.com

Latest Breaking News On - Christopher morabito - Page 4 : comparemela.com

Wedbush Reiterates Outperform Rating for Astria Therapeutics (NASDAQ:ATXS)

Wedbush restated their outperform rating on shares of Astria Therapeutics (NASDAQ:ATXS – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. The firm currently has a $17.00 price objective on the biotechnology company’s stock. ATXS has been the subject of several other research reports. Oppenheimer decreased their target price on […]

United statesChristopher morabitoCitigroup incAstria therapeutics company profileWells fargo companyAstria therapeutics incSecurities exchange commissionTower research capitalPerceptive advisors llcAstria therapeuticsFree reportGet free reportExchange commissionDirector perceptive advisors llcResearch capitalState teachers retirement system

Chief Medical Officer Christopher Morabito Sells 10,000 Shares of Astria Therapeutics Inc

Christopher Morabito, Chief Medical Officer of Astria Therapeutics Inc (NASDAQ:ATXS), has sold 10,000 shares of the company on January 29, 2024, according to a recent SEC Filing.

Astria therapeutics incChief medical officerBiotechnology companyChristopher morabito

Astria Therapeutics, Inc (NASDAQ:ATXS) Q3 2023 Earnings Call Transcript

Astria Therapeutics, Inc. (NASDAQ:ATXS) Q3 2023 Earnings Call Transcript November 13, 2023 Astria Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.63 EPS, expectations were $-0.51. Operator: Good morning and welcome to the Astria Therapeutics Quarter Three 2023 Corporate Update. At this time, all attendees are in a listen-only mode. [Operator Instructions] As a […]

Andrea matthewsDavid shaw quantNoah clauserChristopher morabitoAndrew komjathyChief business officerChief financial officerPivotal phaseHedge fundsWall street analysts are crazy aboutBillionaire david shawQuant models love theseAtopic dermatitisChief commercial officerAndrea matthewsJill milne

Astria Therapeutics, Inc (NASDAQ:ATXS) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Astria Therapeutics Quarter Three 2023 Corporate Update. At this time, all attendees are in a listen-only mode.

Andrew komjathyNoah clauserJill milneDavid shaw quantEun yangLiz higginsChristopher morabitoElizabeth higginsSam slutskySeema shorinAndrea matthewsAstria therapeutics incAstria therapeuticsCall transcript novemberAstria therapeutics quarter threeInvestor relations

Fulcrum Therapeutics Inc (FULC) Announces Chief Medical Officer Departure

Fulcrum Therapeutics Inc (FULC) Announces Chief Medical Officer Departure
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Christopher morabitoJudith dunnBryan stuartFulcrum therapeutics incWall streetChief medical officerFacioscapulohumeral muscular dystrophyChief executive officer

vimarsana © 2020. All Rights Reserved.